Some Antihypertensives Linked to HCC Risk in MASLD

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Clinicians could consider beta blockers instead of calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to help reduce risk.
Medscape Medical News